Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering.
-
04. September 2024 08:00 ET | Quelle: World Orphan Drug Alliance (WODA); Oncopeptides AB, Veld Pharmaceuticals GmbH, Slavpharma GmbH
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
-
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
-
Greater China region, Israel, and Greece, Cyprus and Malta are now also covered by the alliance. With the addition of three new WODA members - RareStone Group, CTS, and Path Pharma - WODA now provides...
-
Under the agreement, the World Orphan Drug Alliance (WODA) has obtained exclusive distribution rights to EGRIFTA SV® (tesamorelin for injection) to be made available under a Named Patient Program. The...